0000769397-23-000169.txt : 20230901 0000769397-23-000169.hdr.sgml : 20230901 20230901205643 ACCESSION NUMBER: 0000769397-23-000169 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230901 FILED AS OF DATE: 20230901 DATE AS OF CHANGE: 20230901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Anagnost Andrew CENTRAL INDEX KEY: 0001661768 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14338 FILM NUMBER: 231233846 MAIL ADDRESS: STREET 1: 111 MCINNIS PARKWAY STREET 2: AUTODESK, INC. CITY: SAN RAFAEL STATE: CA ZIP: 94903 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Autodesk, Inc. CENTRAL INDEX KEY: 0000769397 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 942819853 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 BUSINESS ADDRESS: STREET 1: ONE MARKET, STE. 400. CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 4155075000 MAIL ADDRESS: STREET 1: ONE MARKET, STE. 400. CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: AUTODESK INC DATE OF NAME CHANGE: 19920703 4 1 wk-form4_1693616194.xml FORM 4 X0508 4 2023-09-01 0 0000769397 Autodesk, Inc. ADSK 0001661768 Anagnost Andrew ONE MARKET, SUITE 400 SAN FRANCISCO CA 94105 1 1 0 0 President and CEO 1 Common Stock 2023-09-01 4 S 0 6745 221.15 D 114900 D Common Stock 2023-09-01 4 S 0 12950 221.92 D 101950 D Common Stock 2023-09-01 4 S 0 1008 223.24 D 100942 D Common Stock 2023-09-01 4 S 0 1615 224.04 D 99327 D The sales reported in this form were effected pursuant to a Rule 105b-1 trading plan adopted by the reporting person on 05/26/2023. Shares were sold in various amounts from $220.54 to $221.51 inclusive. The price listed here reflects the average weighted price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The total securities beneficially owned includes 71,319 shares of unvested Restricted Stock Units. Shares were sold in various amounts from $221.54 to $222.43 inclusive. The price listed here reflects the average weighted price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares were sold in various amounts from $222.54 to $223.53 inclusive. The price listed here reflects the average weighted price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares were sold in various amounts from $223.80 to $224.13 inclusive. The price listed here reflects the average weighted price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Melissa Hoge, Attorney-in-Fact for Andrew Anagnost 2023-09-01